Skip to content

Pulmonary rehabilitation in chemical victims

Evaluation of Pulmonary rehabilitation effects on skeletal muscle condition, pulmonary function and quality of life in victims of chemical warfare

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016051127848N1
Enrollment
60
Registered
2016-05-24
Start date
2016-06-04
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic respiratory disorders due to sulfur mustard inhalation. Chronic respiratory conditions due to chemicals, gases, fumes and vapors

Interventions

Intervention 1: Intervention: Pulmonary rehabilitation will be a mix of aerobic endurance training and strength training as well as education in self management. Patients will attend 3 times per week

Sponsors

Health Department of Foundation of Martyrs and Veterans Affairs
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with history of sulfur mustard exposure FEV1 lower than 80% predicted MRC dyspnoea score = 3

Exclusion criteria

Exclusion criteria: any type of debilitating clinical condition that prevents the patient from participating in the rehabilitation program –such as, arthritis any type of clinical condition that will endanger the patient during the physical exercises –such as, uncontrolled cardiac diseases the presence of other non-chemical related pulmonary diseases like asthma active malignancy severe cognitive disorder and psychiatric disease that is associated with memory disorder

Design outcomes

Primary

MeasureTime frame
Endurance Time. Timepoint: before intervention , 6th week, 12th month. Method of measurement: by using an electronically braked cycle ergometer at 70% of Wmax to volitional exhaustion.

Secondary

MeasureTime frame
Lung flows and volumes. Timepoint: before intervention , 6th week, 12th month. Method of measurement: by using body plethysmography.;Single-breath diffusing capacity. Timepoint: before intervention , 6th week, 12th month. Method of measurement: by using DLCO.;Vo2max. Timepoint: before intervention. Method of measurement: by using ergospirometry.;Quadriceps muscle strength. Timepoint: before intervention , 6th week, 12th month. Method of measurement: by using Biodex: Participants will perform 30 sequential volitional maximal contractions at an angular velocity of 90°/s, while seated upright and with the hip joint in 90° of flexion. Quadriceps muscle strength was defined as the highest peak torque (Newton-meter (Nm)).;AT. Timepoint: before intervention. Method of measurement: by using ergospirometry.;O2 pulse. Timepoint: before intervention. Method of measurement: by using ergospirometry.;Quadriceps muscle endurance. Timepoint: before intervention , 6th week, 12th month. Method of measurement: by using Biodex: Participants will perform 30 sequential volitional maximal contractions at an angular velocity of 90°/s, while seated upright and with the hip joint in 90° of flexion. Quadriceps muscle endurance was defined as the total amount of delivered work (Joules (J)) during the set of 30 repetitions.;Cross-sectional area of the rectus femoris (RFCSA). Timepoint: before intervention , 6th week, 12th month. Method of measurement: by Cross-sectional area of the rectus femoris (RFCSA) will be measured by B-mode ultrasonography using an 8 MHz 5.6 cm linear transducer, similar to the method of de Bruin et al.;FFM. Timepoint: before intervention , 6th week, 12th month. Method of measurement: by using single-frequency BIA (Bioelectrical Impedance Analyser).;BMI. Timepoint: before intervention , 6th week, 12th month. Method of measurement: weight(kg)/height^2(m^2).;Total distance walked during 6 minutes. Timepoint: before intervention , 6th week, 12th month. Method of measurement

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad Reza Sedighi Moghadam MD. MPH

Janbazan Medical Engineering Research Center

moghadam_office@yahoo.com+98 21 2241 5367

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 22, 2026